Chemotherapy News and Research

Latest Chemotherapy News and Research

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

Cleveland Clinic Innovations has created a spin-off company to develop a preventive breast cancer vaccine based on research from Cleveland Clinic's Lerner Research Institute.

18 Sep 2013

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.

17 Sep 2013

Dendreon Gets Green Light In Europe

...

17 Sep 2013

Dendreon Gets Greenlight In Europe

...

17 Sep 2013

New method to target, eliminate cancer-supporting macrophages in mouse tumors

When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself.

17 Sep 2013

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the prevention of post-operative nausea & vomiting (PONV).

17 Sep 2013

TSRI scientists find new way to boost effectiveness of anticancer drugs

Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades.

17 Sep 2013

Researchers develop new variety of corked microbottle for drugs

Sustained-release formulations that release drugs over longer periods of time are not the final step in the evolution of “intelligent” drug delivery systems. Modern pharmaceuticals are being designed to be released only in a specific, diseased organ; on cues from our circadian rhythm; or under specific physiological conditions.

17 Sep 2013

Researchers find mucus-regulating protein receptors out of control in uterine, pancreatic cancers

A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).

16 Sep 2013

FDA Panel Urges Fast Approval Of Perjeta For Early-Stage Breast Cancer

...

13 Sep 2013

Funding for antimicrobial resistance research projects in the UK unacceptably small, say researchers

Study of funding awarded to antimicrobial resistance research projects in the UK calls for political leadership and sustained and targeted spending.

13 Sep 2013

Tips for parents of children with cancer

September is Childhood Cancer Awareness Month, and Lisa Diller, MD, chief medical officer of Dana-Farber/Boston Children's Cancer and Blood Disorders Center, advises parents to remain positive if their child is among the 12,000 children in the United States diagnosed with cancer each year.

13 Sep 2013

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

Dana Hayden, MD, colorectal surgeon at Loyola University Health System accepted the 2013 Robert M. Beart, MD, Impact Paper of the Year Award from the American Society of Colon & Rectal Surgeons.

13 Sep 2013

Pertussis incidence among older adults may be under-recognized, study finds

The incidence of pertussis among U.S. adults 50 and older may be greatly under-reported and under-recognized, according to findings from a study conducted by GlaxoSmithKline researchers who analyzed approximately 48 million cases of cough-related illness in the U.S. between 2006 and 2010.

13 Sep 2013

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors.

13 Sep 2013

Researchers potentially reached milestone in vaccine treatment for genital herpes

Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.

13 Sep 2013

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.

12 Sep 2013

Dartmouth researchers find that protein cyclin A plays important role in cell division process

In a study to be published in the journal Nature, two Dartmouth researchers have found that the protein cyclin A plays an important but previously unknown role in the cell division process, acting as a master controller to ensure the faithful segregation of chromosomes during cell division.

12 Sep 2013

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cleveland Clinic creates spin-off company to develop vaccine for preventing breast cancer

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Dendreon Gets Green Light In Europe

Dendreon Gets Greenlight In Europe

New method to target, eliminate cancer-supporting macrophages in mouse tumors

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

TSRI scientists find new way to boost effectiveness of anticancer drugs

Researchers develop new variety of corked microbottle for drugs

Researchers find mucus-regulating protein receptors out of control in uterine, pancreatic cancers

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

FDA Panel Urges Fast Approval Of Perjeta For Early-Stage Breast Cancer

Funding for antimicrobial resistance research projects in the UK unacceptably small, say researchers

Tips for parents of children with cancer

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

Pertussis incidence among older adults may be under-recognized, study finds

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers potentially reached milestone in vaccine treatment for genital herpes

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Dartmouth researchers find that protein cyclin A plays important role in cell division process

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in